Keywords
How to Cite
Abstract
Мазкур мақолада мия ва орқа мия ўсмалари, уларнинг турлари, ташхиси ва замонавий даволаш усуллари кўриб чиқилган. Невро-онкологиянинг асосий мақсадлари ва вазифалари, шунингдек, ўсмаларнинг келиб чиқиш хусусиятлари, клиник белгилари ва уларга қарши даволаш стратегиялари муҳокама қилинган. Мақола мия ўсмаларига доир турли илмий тадқиқотларни умумлаштирган ҳолда, уларнинг таъсирини пасайтириш ва беморларнинг ҳаёт сифатини яхшилашга йўналтирилган тавсияларни таклиф этади.
References
1. Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., ... & Ellison, D. W. (2016). The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica, 131(6), 803-820.
2. Ostrom, Q. T., Cioffi, G., Gittleman, H., Patil, N., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2019). CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012–2016. Neuro-Oncology, 21(Suppl_5), v1-v100.
3. Wen, P. Y., & Kesari, S. (2008). Malignant gliomas in adults. The New England Journal of Medicine, 359(5), 492-507.
4. Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., ... & Mirimanoff, R. O. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England Journal of Medicine, 352(10), 987-996.
5. Reardon, D. A., & Wen, P. Y. (2015). Targeted therapies for malignant gliomas: current status and future directions. Oncology, 29(6), 419-429.
6. Hegi, M. E., Diserens, A. C., Gorlia, T., Hamou, M. F., de Tribolet, N., Weller, M., ... & Stupp, R. (2005). MGMT gene silencing and benefit from temozolomide in glioblastoma. New England Journal of Medicine, 352(10), 997-1003.
7. DeAngelis, L. M. (2001). Brain tumors. New England Journal of Medicine, 344(2), 114-123.
8. Walker, M. D., Alexander, E., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., ... & Wise, G. (1978). Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. Journal of Neurosurgery, 49(3), 333-343.
9. Duffau, H. (2005). Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. The Lancet Neurology, 4(8), 476-486.
10. Batchelor, T. T., & Reardon, D. A. (2009). Treatment of recurrent glioblastoma: current challenges and future approaches. Neuro-Oncology, 11(1), 6-16.
This work is licensed under a Creative Commons Attribution 4.0 International License.
